Quarterly and Full-Year Growth
Q4 adjusted net sales grew 17% (in line with prior range); Q4 adjusted EPS was $0.76. For fiscal 2025, adjusted net sales grew 12% to $1.14 billion and adjusted EPS was $3.92.
Strong Backlog and Bookings
Consolidated bookings remained strong with backlog up over 102% year-over-year at quarter end. Agtech backlog increased ~239% with organic backlog up ~187%.
Profitability Metrics
Q4 adjusted operating margin was 10.8% and adjusted EBITDA margin was 13.6%. For full-year 2025, adjusted operating margin was 13.3% and adjusted EBITDA margin was 16.3%.
Cash Generation & Liquidity
Generated $32 million in operating cash flow in the quarter and $137 million for the year; year-end cash of $116 million and $394 million available on revolver. Full-year free cash flow was ~8% of sales.
OmniMax Acquisition Closed and Scale Expanded
OmniMax acquisition closed Feb 2, 2026. Adjusted 2025 OmniMax revenue (pro-forma) ~ $566 million and adjusted EBITDA ~ $109 million. With OmniMax, 2026 combined net sales guidance is $1.76B–$1.83B (approx. 57% growth at midpoint) with ~5% organic growth; Residential will be >80% of total business in 2026.
Synergy Upside and Early Integration Wins
Original synergy plan of $20 million was updated to $24 million run-rate synergies for 2026, including commercial synergies; approximately $15 million of synergies will flow to 2026 EBITDA with the balance in 2027. Integration Management Office (IMO) and 20 IPTs are operational with daily tracking and early cross-selling activity underway.
Margin Expansion Expected at Company Level in 2026
2026 adjusted EBITDA margin guidance is 17.6%–17.8% vs 16.3% in 2025 (approx. +140 basis points). Management estimates combined contribution of ~ $70 million to adjusted operating income and ~$120 million to adjusted EBITDA from OmniMax plus synergies (includes intangible amortization impact).
Deleveraging Roadmap
Financing completed with two term loans ($1.3B aggregate) and $500M revolver; sale proceeds from eBOS ($70M) applied to debt. Company expects net debt < $1.1B end of 2026 and targets ~2.5x adjusted EBITDA leverage within ~24 months (by Q1 2028).
Active Portfolio Management
Completed sale of Terrasmart eBOS for $70M (Feb 2026); renewables racking/foundations sale process ongoing with proceeds expected to be applied to debt reduction.